Artificial intelligence (AI) is gradually becoming part of the modern healthcare ecosystem, and hematology is one of the areas of medicine where such technologies can be applied. From analysing vast amounts of data to recognizing patterns, assessing risks, and supporting treatment decisions, AI can contribute to making diagnosis and care more efficient and precise. An article published in Blood journal explores how AI and machine learning are being leveraged in hematology to improve diagnosis, estimate risks, and personalise treatment.
Understanding the Role of AI in Hematology
Hematology is a medical discipline that works with substantial amounts of data. Blood tests, peripheral blood smear, bone marrow aspirate and biopsy, flow cytometry, molecular assays, imaging, and patient history are some of the crucial data points that need to be analysed to arrive at a diagnosis and develop a treatment plan. The ability to review and interpret this information is essential for hematologists.
AI and machine learning can help clinicians with the analysis of peripheral blood smears, bone marrow aspirate and biopsy, flow cytometry data, and other laboratory tests. Researchers have already trained algorithms to identify patterns in blood smear and contribute to diagnosing blood disorders.
However, it is essential to recognize that AI is not going to replace hematologists. Instead, it can serve as an additional tool that can help doctors review and analyse data to detect patterns that may not be immediately apparent.
Supporting Earlier and More Accurate Diagnosis
The ability of AI to recognise patterns can be instrumental in helping clinicians identify disease at an early stage. Blood disorders can be challenging to diagnose, especially when patients present with atypical symptoms or abnormal lab results. Researchers have already trained algorithms to analyse combinations of clinical and laboratory parameters to identify patterns that can be used to detect diseases.
Researchers are also exploring how AI can be leveraged to support the interpretation of blood-cell morphology. Algorithms can analyse blood-cell images to help identify abnormal cells and potential disease patterns. The article highlights several studies in laboratory hematology that leverage image analysis algorithms to support diagnosis, identify patterns, screen for diseases, and predict patient outcomes. The ability of AI to detect irregularities is especially valuable when such technologies are incorporated into the broader diagnostic process.
Considering Risks and Treatment Options
Hematology often involves estimating the course of the disease and determining the best treatment options. In many cases, clinicians need to consider multiple variables when evaluating the likelihood that a patient is going to respond to a particular therapy. Researchers note that AI can help hematologists estimate risks and support treatment planning. Experts at King George’s Medical University (KGMU) note that AI can help clinicians analyse data to predict disease patterns and support treatment options for patients with complex blood disorders.
At the same time, the experts note that clinicians should remain actively involved in the care process. The collaboration between doctors and AI can be especially valuable in complex cases when treatment options need to be considered.
AI and Personalised Hematology
The future of hematology is personalised medicine. Patients with the same diagnosis can have significantly different disease presentations, prognosis, and treatment options. The article notes that AI can help clinicians review patients’ clinical, laboratory, and genetic data to identify patterns that can be used to guide care.
However, it is essential to remember that AI should be used as an additional tool that can help estimate risks and support treatment options. Algorithms should not be used to make clinical decisions on their own, especially when it comes to diagnosis and treatment.
The Need for Responsible AI
The article highlights the ethical implications of using AI in hematology. First of all, it is essential to remember that such technologies are only as good as the data they are trained on. If the data is limited, biased, or outdated, the results of such algorithms may be inaccurate or irrelevant. Second, patient privacy and data security are paramount, which is why hematology systems that utilise AI should be built with robust cybersecurity infrastructure.
The experts at KGMU discuss ethical concerns related to patient data and note that AI predictions should be validated by clinicians before they are used to guide treatment. The use of such technologies in hematology requires transparency, responsible use, and clinical validation.
Digital Infrastructure Is the Future of Hematology
Hospitals and healthcare facilities can benefit from leveraging AI in hematology to improve care and make it more efficient. However, they need to invest in the digital infrastructure that will allow such technologies to be utilised to their fullest potential. Integrated hospital information systems can help clinicians store and access patient data more efficiently, which can make diagnosis and treatment planning easier. The ability to analyse data using decision-support systems can help doctors detect patterns and make more accurate predictions.
Digital health platforms can be instrumental in building such an ecosystem, as they can help organisations collect and store patient data in a structured manner. Once such infrastructure is in place, healthcare facilities can invest in additional technologies, including AI-based decision-support systems.
AI Is Not the End, but the Beginning of Hematology Innovation
AI is unlikely to disrupt hematology as we know it. Instead, it will be one tool among many that can help hematologists improve care and make it more efficient. The article highlights how AI can be leveraged in different areas of hematology, from analysing laboratory results and supporting diagnosis to estimating risks and supporting treatment planning. The key to successfully implementing such technologies lies in finding the right balance between human expertise and technological innovation.
While AI can process vast amounts of data to detect patterns and make predictions, hematologists remain crucial to the care process. Their expertise, experience, and ability to communicate with patients are invaluable, and AI should be used as a tool to support them. As such technologies continue to develop, the focus should be on making hematology more personalised and precise to help patients receive the best possible care.
Conclusion
Artificial intelligence can play a significant role in hematology, from helping clinicians analyse and interpret data to supporting diagnosis, estimating risks, and personalising treatment. Recent discussions among hematology experts highlight the potential benefits of such technologies while also emphasising the need for responsible use. The future of hematology will be defined by clinicians and AI working together to make diagnosis and care more efficient and individualised.
American Society of Hematology (ASH). Artificial Intelligence in Hematology. Blood, Volume 146, Issue 19, p. 2283.Read the ASH article
ETHealthWorld / The Economic Times. AI tools can aid blood disorder care: Experts. Published August 24, 2026. The article discusses AI applications in analysing clinical data, predicting disease progression, assessing risks and supporting treatment planning, while emphasising clinical judgement and ethical use.Read the ETHealthWorld article
